
|Articles|May 4, 2012
Paul Dobesh, PharmD, Points Out the Benefits of Combining Anticoagulant and Antiplatelet Treatments
Dr. Dobesh addresses the challenges of achieving efficacy without having the patient bleed when combining anticoagulant and antiplatelet treatments.
Advertisement
Paul Dobesh, PharmD, addresses the challenges in trying to simplify medication regiments in cardiovascular disease to improve clinical outcomes and increase adherence.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch
2
Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC
3
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
4
Review Highlights IGHV Testing Complexities in CLL
5













































